Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 6/2010

Open Access 01-12-2010 | Case Report

Severe akathisia as a side effect of metoclopramide

Authors: Arthur R. Van Gool, Jeanette K. Doorduijn, Caroline Seynaeve

Published in: International Journal of Clinical Pharmacy | Issue 6/2010

Login to get access

Abstract

Case description A case of severe metoclopramide-induced akathisia in a breast cancer patient being treated with chemotherapy is presented, eventually culminating in hospital admission. In retrospect, this adverse effect was not recognized for several weeks because the prescription had not been properly recorded in the chart, the patient initially denied using the drug, and extensive psychological adjustment difficulties were also present. Conclusion Movement disorders as an adverse effect of metoclopramide have been described on a regular basis over the past decades. Case reports such as this confirm there is under-recognition of adverse effects and emphasize the need to take a comprehensive medication history and recognize well known side effects of medications such as metoclopramide.
Literature
1.
go back to reference Matok I, Gorodischer R, Koren G, Sheiner E, Wiznitzer A, Levy A. The safety of metoclopramide use in the first trimester of pregnancy. N Engl J Med. 2009;360(24):2528–35.CrossRefPubMed Matok I, Gorodischer R, Koren G, Sheiner E, Wiznitzer A, Levy A. The safety of metoclopramide use in the first trimester of pregnancy. N Engl J Med. 2009;360(24):2528–35.CrossRefPubMed
2.
go back to reference Pasricha PJ, Pehlivanov N, Sugumar A, Jankovic J. Drug insight: from disturbed motility to disordered movement—a review of the clinical benefits and medicolegal risks of metoclopramide. Nat Clin Pract Gastroenterol Hepatol. 2006;3:138–48.CrossRefPubMed Pasricha PJ, Pehlivanov N, Sugumar A, Jankovic J. Drug insight: from disturbed motility to disordered movement—a review of the clinical benefits and medicolegal risks of metoclopramide. Nat Clin Pract Gastroenterol Hepatol. 2006;3:138–48.CrossRefPubMed
3.
go back to reference Dingli K, Morgan R, Leen C. Tetanus versus acute dystonic reaction caused by metoclopramide. Br Med J. 2007;334:899–900.CrossRef Dingli K, Morgan R, Leen C. Tetanus versus acute dystonic reaction caused by metoclopramide. Br Med J. 2007;334:899–900.CrossRef
4.
go back to reference Bateman DN, Rawlins MD, Simpson JM. Extrapyramidal reactions with metoclopramide. Br Med J. 1985;291:930–2.CrossRef Bateman DN, Rawlins MD, Simpson JM. Extrapyramidal reactions with metoclopramide. Br Med J. 1985;291:930–2.CrossRef
5.
go back to reference Miller LG, Jankovic J. Metoclopramide-induced movement disorders. Arch Intern Med. 1989;149:2486–92.CrossRefPubMed Miller LG, Jankovic J. Metoclopramide-induced movement disorders. Arch Intern Med. 1989;149:2486–92.CrossRefPubMed
6.
go back to reference Ganzini L, Casey DE, Hoffman WF, McCall AL. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders. Arch Intern Med. 1993;153:1469–75.CrossRefPubMed Ganzini L, Casey DE, Hoffman WF, McCall AL. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders. Arch Intern Med. 1993;153:1469–75.CrossRefPubMed
7.
go back to reference Bijl D. Metoclopramide en bewegingsstoornissen. Geneesmiddelen Bull. 2009;43:114. Bijl D. Metoclopramide en bewegingsstoornissen. Geneesmiddelen Bull. 2009;43:114.
8.
go back to reference Van der Padt A, van Schaik RHN, Sonneveld P. Acute dystonic reaction to metoclopramide in patients carrying homozygous cytochrome P450 2D6 genetic polymorphisms. Neth J Med. 2006;64:160–2.PubMed Van der Padt A, van Schaik RHN, Sonneveld P. Acute dystonic reaction to metoclopramide in patients carrying homozygous cytochrome P450 2D6 genetic polymorphisms. Neth J Med. 2006;64:160–2.PubMed
10.
go back to reference Stanley M, Lautin A, Rotrosen J, Gershon S, Kleinberg D. Metoclopramide: antipsychotic efficacy of a drug lacking potency in receptor models. Psychopharmacology (Berl). 1980;71:219–25.CrossRef Stanley M, Lautin A, Rotrosen J, Gershon S, Kleinberg D. Metoclopramide: antipsychotic efficacy of a drug lacking potency in receptor models. Psychopharmacology (Berl). 1980;71:219–25.CrossRef
Metadata
Title
Severe akathisia as a side effect of metoclopramide
Authors
Arthur R. Van Gool
Jeanette K. Doorduijn
Caroline Seynaeve
Publication date
01-12-2010
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 6/2010
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-010-9444-3

Other articles of this Issue 6/2010

International Journal of Clinical Pharmacy 6/2010 Go to the issue